CClinicalTrials.gg
CompletedNCT03083964APP-MEUpdated Nov 28, 2023

Addressing Place and People Micro Environments in Weight Loss Disparities

An interventional study of Usual Care and Priming in Obese, sponsored by Indiana University. Completed at 1 site in United States. Open to female participants aged 35 Years to 64 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-11-28.

Sponsored by Indiana University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
350
Allocation
Randomized
Ages
35 Years to 64 Years
Sex
Female
01

Study summary

The purpose of this study is to A) capture obesogenic cues that occur in daily life, and B) to deliver cue alerts. Investigators hypothesized that A) black women experience more cues, B) racial disparities in obesity are reduced in models that adjust for cues, and C) the priming arm will achieve a weight loss of 2kg or more. Investigators will explore whether racial disparities in weight loss differ between the groups receiving usual care or those receiving cues.

Read the detailed description

Aim 1: After participants have been consented over the phone or in clinic, the Research Assistants (RA) will schedule a baseline assessment. Baseline interviewer administered survey questions, assessments, and equipment set-up will be completed in participants' homes to allow a physical environment assessment of the home. Assessments and surveys will be carried out using Research Electronic Data Capture (REDCap; see Resources). The in-home baseline assessment piloted for the proposed study takes 1 to 1.5 hours. Global Positioning System (GPS) locating, accelerometry, bite monitoring, and EMA surveys will operate through the mHealth app over the immediate 2-4 week period. For GPS locating, the mHealth app uses software that identifies and sends the longitude and latitude at the time of EMA response to a secure IU server. Software then determines the address of the location and whether it is the participant's home, work, restaurant, retail store, etc. For messaging, the mHealth app uses "Push Notification" to deliver EMA requests to the device (i.e., smartphone). This bypasses the phone carrier's Short Message Service (SMS) gateway, which is not always reliable or secure. The mHealth app makes sure the messages are delivered and secure. Participants receive a notification and open the application to answer the EMA questions. The database is located in a secure network within Indiana University servers. None of the data are stored inside the smartphone at rest. The actual questions are very brief with radio button responses.

At the end of the 2-4 week window, RAs will return to the home to collect the accelerometer and bite counter which takes about 1 hour. The accelerometer and bite counter are to be marked by the RA with the study participants ID and data are retrieved. At this time, participants who responded to 75% or more of the messages over the 2-4 week period, will be randomized to Usual Care (UC) or Priming Arm for Aim 2 and given instruction on the next steps of study participation. Randomization will be carried out within each race group to ensure a balance in the number of subjects between the two treatment arms. The Investigator will computer-generate randomization lists in field envelopes to be provided to the RAs for treatment assignment.

Aim 2: The second aim of the study will last 6 months. Both UC and Priming arms will have full access to Healthy-Me coaches and classes as well as receive training and access to the mHealth app. When study participation is excluded, all apps and associated data will be removed from the smartphone. At no time will Patient Health Information (PHI) be stored on the smartphone. Smartphones will only be identified by study ID number and the developer will only have access to the participants' study ID number and smartphone data collected by the mHealth app. Subjects in UC and Priming will undergo similar assessments and procedures; however, the Priming arm participants will, in addition receive 6-8 message alerts per day. The application and notifications that will be used in the Priming arm will be built from each participants own library to be delivered at times and in locations that their Aim 1 data indicate they often experience an eating or sedentary cue. In short, this intervention counters an obesogenic cue with a "healthy" prime in real-time and location.

Finally, following 6 months of UC or Priming, blinded RAs will return to participants home to complete 6-month follow-up assessment and collect all study related equipment. The final assessment and surveys will take about 1-1.5 hours and all data captured will also be carried out in REDCap.

02

Conditions studied

  • Obese

Browse trials for

Keywords

  • Middle aged women
  • 35-64yrs
  • BMI= >30
03

In context

Weight Loss

1,766 studies on the registry are indexed under Weight Loss; 277 are open to participants now.

This study's enrollment of 350 is above the median of 73 across 1,496 interventional studies indexed under Weight Loss.

Browse Weight Loss studies →

Lead sponsor

Indiana University is the lead sponsor of 958 studies on the registry; 200 are open to participants now.

Of its 142 completed or terminated interventional studies of FDA-regulated products, 112 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
35 Years to 64 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Electronic Screener Data (EMR):

    1. Aged 35 to 64 years.
    2. Female.
    3. BMI ≥ 30.
    4. Healthy-Me referral or Eligible for Healthy-Me

      Self-reported Screener Data:

    5. English as primary language.
    6. Self-identified non-Hispanic black or African-American, or non-Hispanic white.
    7. A permanent address.

Exclusion criteria

Exclusion Criteria:

  • Electronic Screener Data (EMR):

    1. Severe illness that might be associated with weight loss, such as cancer.
    2. Use of weight loss medications (rare due to cost of the medications).
    3. History of bipolar disorder or psychosis.

      Self-reported Screener Data:

    4. Severe cognitive impairment (≥3 errors on a 6-item cognitive screen).
    5. Unwilling or unable to provide informed consent.
    6. Bariatric surgery already completed or planned within 12 months.
    7. Pregnant or nursing in past 6 months, or plans to become so within 12 months.
    8. Residence outside of Marion County, Indiana.
    9. Substance abuse (for alcohol; ≥2 on CAGE questionnaire).
    10. Current smoking or tobacco use.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
350 participants (actual)

Study arms

  • Active comparator
    Usual Care

    Usual care involves a lifestyle coaching intervention delivered in primary care sites.

    Behavioral: Usual Care

  • Experimental
    Priming

    Priming involves usual care plus just in time reminder messages related to mindful eating and physical activity.

    Behavioral: Priming

Interventions

  • BehavioralUsual Care

    Usual care is not considered an intervention. This arm of the study involves a lifestyle coaching intervention delivered in primary care sites to the subjects.

  • BehavioralPriming

    The intervention is a just in time eating or physical activity reminder. Each individual participant reports physical activity goals as well as times that they most often eat. This information is used to select for that individual the best time to send an eating or physical activity reminder. The reminders come to the participant's smartphone or a study provided smartphone. Participants will receive reminder 2 to 4 times per day depending on their goals and behavior pattern.

06

What researchers measure

Primary outcomes

  1. Proportion of participants that lose 2 kilograms of weight between baseline and 6 month follow-up

    Participants are weighed at baseline and 6 months to access if proportion is losing 2kg of body weight or more by 6 months.

    Time frame: baseline and 6 months

Secondary outcomes

  1. Physical activity frequency

    Outcomes include ecological momentary assessments that query up to 12 times per day to address physical activity using smartphones.

    Time frame: 6 months

  2. Eating Frequency

    Participants will self-report eating behavior for 3 week periods at baseline and follow-up at 6 month.

    Time frame: 6months

  3. Depression

    Depression is measured using the patient health questionnaire PHQ-4

    Time frame: 6 months

  4. Anxiety

    Anxiety is measured using the patient health questionnaire PHQ-4

    Time frame: 6 months

07

Study locations

1 site
  • Daniel Clark
    Indianapolis, Indiana 46202, United States
08

References and documents

Publications

  • Clark DO, Keith NR, Ofner S, Hackett J, Li R, Agarwal N, Tu W. Environments and situations as correlates of eating and drinking among women living with obesity and urban poverty. Obes Sci Pract. 2021 Sep 1;8(2):153-163. doi: 10.1002/osp4.557. eCollection 2022 Apr. PubMed 35388340 ↗
  • Srinivas P, Bodke K, Ofner S, Keith NR, Tu W, Clark DO. Context-Sensitive Ecological Momentary Assessment: Application of User-Centered Design for Improving User Satisfaction and Engagement During Self-Report. JMIR Mhealth Uhealth. 2019 Apr 3;7(4):e10894. doi: 10.2196/10894. PubMed 30942698 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 28, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03083964
Lead sponsor
Indiana University
Responsible party
NiCole Keith (Professor, Department of Kinesiology, Indiana University) — Principal investigator
First posted
Mar 20, 2017
Start date
Jan 18, 2017
Primary completion
Dec 11, 2021
Completion
Dec 11, 2021
Last update
Nov 28, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion